A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium risk
about
A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium risk
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A randomized, double blind, pl ...... population at low-medium risk
@ast
A randomized, double blind, pl ...... population at low-medium risk
@en
A randomized, double blind, pl ...... population at low-medium risk
@nl
type
label
A randomized, double blind, pl ...... population at low-medium risk
@ast
A randomized, double blind, pl ...... population at low-medium risk
@en
A randomized, double blind, pl ...... population at low-medium risk
@nl
prefLabel
A randomized, double blind, pl ...... population at low-medium risk
@ast
A randomized, double blind, pl ...... population at low-medium risk
@en
A randomized, double blind, pl ...... population at low-medium risk
@nl
P2093
P2860
P921
P3181
P1433
P1476
A randomized, double blind, pl ...... population at low-medium risk
@en
P2093
Fan-bo Meng
Guo-gang Zhang
Guo-ping Yang
Jian-lin Ma
Shi-juan Lu
Shui-ping Zhao
Xiao-hui Li
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0117560
P407
P577
2015-01-01T00:00:00Z